bioRxivGeneticsPreprint
Stress attenuation by the adrenergic-specific lncRNA NESPR prevents cell death in neuroblastoma cells
Louis DelhayeiD, Dries RombautiD, Eric James de BonyiD, Eva D’haeneiD, Tiago F. BrazãoiD, Lisa DepesteliD, Bieke DecaestekeriD, Stéphane Van HaveriD, Ramiro MartineziD, Laudonia Lidia DipaloiD, Juliette RoelsiD, Kimberly VerniersiD, Nurten YigitiD, Jasper AnckaertiD, Björn MenteniD, Sarah VergultiD, Pieter Van VlierbergheiD, Stephen S. RobertsiD, Giorgio MilazzoiD, Giovanni PeriniiD, Takaomi SandaiD, Frank SpelemaniD, Sven EyckermaniD, Pieter MestdaghiD
Abstract
Neuroblastoma is a pediatric cancer of the sympathetic nervous system characterized by heterogeneous cell states that mirror normal differentiation trajectories. Each state is governed by a core regulatory transcriptional circuitry that reinforces cell identity through an autoregulatory feedforward loop. We identified the long non-coding RNA NESPR as specifically expressed in adrenergic neuroblastoma cells. NESPR expression correlates with high-risk neuroblastoma clinical parameters and poor patient survival. NESPR is located within an insulated gene neighborhood alongside PHOX2B, a master transcription factor of the adrenergic identity. NESPR depletion reduced cell proliferation and increased caspase activity in neuroblastoma cell lines, and NESPR knockout in a neuroblastoma zebrafish model led to reduced tumor penetrance. Subcellular localization revealed NESPR to be a cytosolic long non-coding RNA, suggesting a trans-regulatory function. RNA-sequencing following NESPR depletion revealed a shift from an adrenergic to a mesenchymal cell state, due to proteotoxic stress-induced molecular reprogramming. These findings suggest NESPR as a regulator of neuroblastoma cell identity with potential therapeutic opportunities in high-risk neuroblastoma cases.
- organism: human
- organism: zebrafish
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: cell type annotation
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Malignant Schwann cell precursors mediate intratumoral plasticity in human neuroblastoma
T. K. Olsen, J. Otte, … N. Baryawno·bioRxiv·May 4, 2020
- RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity
Shivendra Vikram Singh, Jie Fang, … Jun J.J. Yang·Nature CommunicationsPeer-reviewed·Sep 17, 2025
- Inhibition of OCT4 Binding at the MYCN Locus Induces Neuroblastoma Cell Death Accompanied by Downregulation of Transcripts with High-Open Reading Frame Dominance
K. Nakatani, H. Kogashi, … Y. Suenaga·bioRxiv·Jun 8, 2023
- Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State
N. Weichert-Leahey, H. Shi, … A. T. Look·bioRxiv·Feb 28, 2023
- An immature subset of neuroblastoma cells synthesizes retinoic acid and depends on this metabolite
T. van Groningen, C. U. Niklasson, … J. van Nes·bioRxiv·May 18, 2021
- Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting metastasis
Lucía Fanlo, Soledad Gómez‐González, … Gwenvaël Le Dréau·bioRxiv·Nov 26, 2021